We examined glomerular synthesis of the 5-lipoxygenase metabolite, LTB4, in normal and immune-injured rat glomeruli.
1. Abbreviations used in this paper: CBGG, cationic bovine gamma globulin; GBM, glomerular basement membrane; LTB4, leukotriene B4; 5-HPETE, 5-hydroperoxy-eicosatetraenoic acid; NSN, nephrotoxic serum nephritis; PHN, passive Heymann nephritis. glomerular synthesis of 12-HETE has been demonstrated in rats with antibody-mediated glomerular injury, nephrotoxic serum nephritis (NSN) ' (3) . This enhancement of enzymatic activity could play a role in the development of glomerular disease, since 12-HETE has a proinflammatory effect on neutrophils.
In recent years much interest has focused on the 5-lipoxygenase pathway of oxidative arachidonic acid metabolism. This pathway produces 5-hydroperoxyeicosatetraenoic acid (5-HPETE), which is converted to several leukotrienes. Leukotriene C4 (LTC4) and leukotriene D4 (LTD4) were previously known as slow reacting substance of anaphylaxis (4, 5) . Leukotriene B4 (LTB4) is produced by stimulated inflammatory cells, mainly neutrophils and macrophages (6) , and is present in perfusate obtained from antigen challenged lung (7) . LTB4 is a powerful chemotactic and chemokinetic agent for granulocytes, stimulates the generation ofreactive oxygen radicals in neutrophils and induces leukocyte adhesion to the endothelial surface (8) (9) (10) . When injected intradermally with PGE2, LTB4 increased permeability ofdermal vessels to a degree dependent on its dose, although LTB4 alone had no effect on capillary permeability (1 1-14) . Therefore LTB4 is considered to be a major mediator of inflammation, including enhanced vascular permeability, and could play a part in the pathogenesis of glomerulonephritis.
The aims of the present study were: first, to examine the ability of normal glomerular cells to metabolize arachidonic acid through the 5-lipoxygenase pathway and synthesize LTB4; second, to examine glomerular synthesis of LTB4 in infiltrative and noninfiltrative models of immune glomerular disease. The infiltrative model we examined was the heterologous phase of NSN, which is characterized by heavy glomerular infiltration with neutrophils. Two noninfiltrative, nonproliferative models were examined; passive Heymann nephritis (PHN) and cationic bovine gamma globulin (CBGG)-induced glomerulonephritis, both pathologically similar to human membranous nephropathy.
as previously described (15, 16) . Female New Zealand white rabbits received intradermal injections of rat GBM, 5 mg of GBM per rabbit, in complete Freund's adjuvant as we have previously described (3) . The injections were repeated after 2 wk. 1 mo after the initial injection the nephrotoxicity of the rabbit serum was evaluated by the development of proteinuria after injections of 1 ml serum i.v. in 300 g male Sprague-Dawley rats. Immunofluorescent examination of glomeruli from injected rats confirmed linear staining ofGBM for rabbit IgG and rat C3. 1 ml of rabbit serum contained 14.4 mg of IgG by radial immunodiffusion (3) .
Preparation ofanti-FxJA antibody. Fx1A tubular antigen was prepared from Sprague-Dawley renal cortex (17) . New Zealand white rabbits were immunized with 10 mg Fx IA in complete Freund's adjuvant in the rear foot pads. 2 wk later, a booster immunization with the same preparation was given in multiple subcutaneous sites and repeated biweekly. Rabbits were periodically bled and antibody against tubular antigen assessed by indirect immunofluorescence. Antiserum against FxlA was heat-inactivated (560C, 30 min) and absorbed with 0.1 ml normal rat serum and subsequently with 1 ml packed rat blood cells per ml antiserum. The IgG fraction of the rabbit antiserum was prepared by precipitation with half-saturated (NH4)2SO4 followed by DEAE cellulose column chromatography in 0.0175 M potassium phosphate buffer, pH 6.30. This preparation is referred to as Heymann antibody; its specificity was confirmed by indirect immunofluorescence (18).
Preparation of the CBGG. BGG was cationized as previously described (19, 20) . 2 g BGG was dissolved in 20 ml 0.01 M NaCl, mixed with 40 ml ethylenediamine, and the pH adjusted to 7.0 with 2 N HCI. 4 g EDC was added and the pH was maintained at 7.0. The mixture was left overnight at room temperature, then dialyzed against 0.15 M NaCl for 24 h. Cationic BGG prepared by this procedure has a pl ranging from 9.5 to 11.5.
Experimental models. Sprague-Dawley rats, 200-300 g were divided into four groups: a control group, a NSN group, a PHN group, and a group with CBGG-induced membranous nephropathy. In each ofthe four groups kidney tissues were examined by light, immunofluorescence and electron microscopy, and glomeruli were isolated for LTB4 measurement.
NSN was induced in rats by injecting 1 ml of anti-GBM serum i.v.; the rats were sacrificed 48 h later (3). To induce PHN, 60 mg of IgG fraction ofanti-Fx I A was injected into rats in three divided doses given 1 h apart, via tail vein ( 18). Rats were sacrificed 18 d later, during the peak of the autologous phase. For induction of the CBGG model, rats were immunized in the foot pads with 1 mg CBGG in complete Freund's adjuvant. 7 d later the rats received daily intravenous antigen challenge with increasing doses ofCBGG for 5 d (day 1: 2 mg, day 2: 4 mg, day 3: 6 mg, day 4: 8 mg, day 5: 10 mg) and were killed 3-4 d after the last intravenous injection ofantigen. The pathologic features ofthe CBGG model have been described recently (20) .
X-Irradiation to the CBGG model. To exclude the possibility that circulating or infiltrating neutrophils were the source of measured LTB4, leukocytes were depleted by total body x-irradiation (21). 5 d after foot pad immunization with CBGG each rat received a total dose of 1,000 rad (Theratron model 780; Atomic Energy of Canada, Ltd., Ottawa, Canada); an 8 cm thick cerrobend shield was placed around the abdomen and the lumbar spine region shielding the kidneys. 4 days later, blood leukocytes were ennumerated and rats received four intravenous injections ofCBGG; 2, 4, 6, and 8 mg, 12 h apart. This protocol was adapted to develop the disease in a shorter period of time due to the decreased life span of the irradiated rats. One day after the last CBGG injection proteinuria was examined, a blood sample was drawn for measurement of total white blood cell and neutrophil count, and the rats were killed.
In vivo inhibition ofLTB4 synthesis with BW75SC. To determine the effects of 5-lipoxygenase inhibition in the CBGG model ofglomerulonephritis we administered the cyclo-and lipoxygenase inhibitor BW755C to rats for 3 d after the last antigenic challenge. Six rats were preimmunized and challenged for four successive days starting a week later, as described above. On days 11-13, (3, 18, 20) . Sections were layered with goat antiserum to rat IgG (rhodamine conjugated), bovine IgG, rabbit IgG or rat complement C3 (fluorescein conjugated), all diluted at 1:20. There was no cross-reactivity between any of the antisera among themselves or with rat IgG, bovine IgG, or rat serum (for C3) in double immunodiffusion. Coded sections (to prevent observer bias) were examined in a microscope (Ernst Leitz Inc., Wetzlar, West Germany).
Electron microscopy (EM). Small (1 mm in each dimension) portions of renal cortex were immersion fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate adjusted to pH 7.3. The tissue was postfixed in (Os 04) and embedded in Spurr's epoxy. Ultrathin (50 nm) sections were cut, picked up on uncoated nickel grids, and stained with uranyl acetate and lead citrate. Specimens (coded to prevent observer bias)
were evaluated in an electron microscope (201 C; Philips Medical Electronics Div., Piscataway, NJ) for the number and size of electron dense deposits in subendothelial, intramembranous, subepithelial, and mesangial glomerular sites, in a manner similar to that previously described (18, 20) .
Light microscopy (LM). Tissue was immersion fixed in 10% formalin buffered to pH 7.5 with 0.01 M sodium phosphate for 24 h. The tissue was then processed through graded alcohols and xylenes and infiltrated in molten Paraplast (Fisher Scientific). The tissue was embedded, sectioned at 2 um and stained with periodic acid silver-methenamine, and with hematoxylin and eosin. Coded sections were examined in a light microscope (American Optical, Buffalo, NY).
Glomerular isolation and incubation. After small portions of the cortex were taken for electron, light and immunofluorescence microscopy, the remainder of the kidney tissue was placed in ice-cold PBS (0.15 M NaCl, 0.01 M sodium phosphate, pH 7.6) and used for glomerular isolation. Glomeruli were isolated by a differential sieving technique (20) . The cortex was separated from the medulla and minced to a pastelike consistency. The minced cortical paste was passed through a 106-,sm metal sieve to remove large tubular fragments and suspended in PBS. This suspension was triturated and poured over a 75-um sieve. The glomeruli trapped on the 75-Mm sieve were collected and suspended in PBS. The purity of the glomerular preparation was assessed by light microscopy and varied between 92 and 98%. The isolated glomeruli were transferred to a siliconized glass tube and were suspended in Earle's balanced salt solution with 20 mM Hepes, 3.0 AM calcium ionophore (A23 187) and 2 mM reduced glutathione, at a total volume of 1 ml. In some experiments we added the cyclo-and lipoxygenase inhibitor BW755C (50 Atg/ml) or [3H1-arachidonic acid, specific activity 80 Ci/mmol (5 X 105 cpm/ml of media yielding 1.8 ng arachidonate/ml). The glomerular suspension was incubated for 30 min at 370C with mild agitation.
Extraction and purification oflipids. Incubation was terminated by acidification to pH 3.5 with 0.1 N HCI and lipids were extracted three times with 3-4 vol of ethyl acetate. The extracted lipids were dried under nitrogen and reconstituted in 100% methanol and then in 5% 1946 methanol in water. The reconstituted lipids were further purified on ODS silica cartridges, pretreated with 1 ml methanol followed by 3-5 ml of water immediately before use. After application of the sample, the cartridge was washed with 2-3 ml of water then the sample was eluted with I ml of methanol. Samples were stored in methanol under N2 at -60'C until separation by reverse phase HPLC and LTB4 measurement by RIA.
HPLC and RIA for LTB4. Samples obtained from glomerular incubation in the presence of calcium ionophore (A23187) were analyzed by HPLC-RIA. Reverse phase HPLC was carried out on an instrument model 5000; Varian Instruments, Palo Alto, CA fitted with a Nucleosil C-18 column. The column was eluted at 0.9 ml/min, with a linear gradient from 93.4% 0.01 M phosphate buffer (pH 7.4), 6% methanol, and 0.6% t-amyl alcohol, to 99.4% methanol with 0.6% t-amyl alcohol (% by volume) over 100 min (23) . Fractions were collected at 1-min intervals, dried under nitrogen and reconstituted in 0.5 ml of PBS containing 1% gelatin. Immunoreactive LTB4 was determined in each fraction using LTB4 antibodies. The sensitivity and the cross-reactivity of the antibodies were previously described (24) .
Radiometric-HPLC. Samples obtained from glomerular incubation with A23 187 and [3H]arachidonic acid were analyzed by HPLC as described above. The radioactivity in each fraction was determined by liquid scintillation counting and was expressed as counts per minute per milligram glomerular protein.
GC-MS. HPLC fractions that comigrated with authentic LTB4 and were shown to contain i-LTB4 peaks, and fractions eluted 2 min before and 2 min after the LTB4 retention time, were further studied by GC-MS by Dr. Ian Blair, Vanderbilt University, Nashville, TN (25) . Briefly, after esterification ofthe fatty acid esters in the HPLC fractions with pentafluorophenol, the bis-trimethylsilyl ether was generated by heating with bis(trimethylsilyl)trifluoroacetamide in pyridine (1:1) (Fig. 3 A) . The amount of i-LTB4 in the HPLC fraction that comigrates with authentic LTB4 from both control rats (n = 9 rats in three experiments) (Fig. 3 B) and those with NSN (n = 10 rats in three experiments) (Fig. 3 C) , did not exceed the background noise of the assay, which resulted from cross reactivity of LTB4 antibodies with other lipid fractions. Likewise, glomeruli isolated from rats with PHN did not synthesize measurable amounts of i-LTB4 (n = 11 rats in four experiments, data not shown). In contrast to control, NSN, and PHN rats, the synthesis of i-LTB4 was greatly enhanced in glomeruli isolated from rats immunized and challenged with CBGG (n = 11 rats in four experiments) (Fig. 3 D) (Fig. 4) .
Glomeruli from normal rats did not reveal any leukotriene peak (data not shown).
Glomerular incubation with lipoxygenase inhibitor. Glomeruli isolated from rats injected with CBGG were incubated with the cyclo-and lipoxygenase inhibitor BW755C, 50 gg/ml. GC-MS. To verify the structural characteristics of the i-LTB4 in glomeruli isolated from CBGG injected rats, selected samples of extracted glomeruli and incubation medium were subjected to GC-MS analysis after HPLC purification. Fractions that comigrated with standard LTB4 and contain peaks of i-LTB4 were identified as authentic LTB4 based on an intense negative ion at m/z 479, identical to the spectrum of standard LTB4. There was close agreement in the quantification of LTB4 by HPLC-RIA and by GC/MS (Table II) .
X-irradiation to the CBGG model Some rats were X-irradiated before intravenous injection of CBGG to minimize the possibility that glomerular LTB4 was derived from circulating leukocytes. Irradiated rats developed 118±14 mg proteinuria/ 24 h, comparable to nonirradiated rats. Glomerular i-LTB4 production was from the total protein determined by sulfosalicylic acid. CBGG rats had 77±8.3 mg protein in the 24-h urine collection, whereas rats given BW755C excreted only 28.4±11.8 mg/24 h (P < 0.01). However, the endogenous creatinine clearance in the treated rats was 0.24±0.07 ml/min, compared with 0.55±0.05 ml/min in the saline-treated group (P < 0.01). There was no correlation between proteinuria and endogenous creatinine clearance between the treated and control groups. Moreover, while the creatinine clearance was reduced to 44% ofthe control group, the proteinuria was reduced to 37% ofthe control value in treated rats. LTB4 synthesis in the treated rats was 1.06 ng/mg glomerular protein, versus 2.96 ng/mg in untreated controls. (20, (27) (28) (29) . On the other hand, the data on the role of the lipoxygenase metabolites in glomerular inflammation are few and the capacity of the glomeruli to synthesize 5-lipoxygenase products has not been established. In this study, we demonstrate glomerular synthesis of the 5-lipoxygenase metabolite LTB4 in the CBGG-induced model of immune glomerular disease. Our studies were always conducted with calcium ionophore added to isolated glomeruli, in order to stimulate 5-lipoxygenase. This model, pathologically similar to human membranous nephropathy, is a nonproliferative and noninfiltrative model, and injury is independent of serum complement and circulating leukocytes (30) . The enhanced glomerular synthesis of LTB4 was demonstrated by HPLC/RIA, by radiometric HPLC after incubation ofisolated glomeruli with tritiated arachidonic acid, and by GC/MS, which unequivocally demonstrated the presence of authentic LTB4 in the HPLC fractions shown to contain i-LTB4. Furthermore, synthesis of immunoreactive LTB4, measured by HPLC-RIA, was inhibited by the cyclo-and lipoxygenase inhibitor BW755C. Although we included reduced glutathione in the incubation medium, we did not observe any sulfidopeptide leukotriene products or their major metabolite, LTE4. We cannot exclude the possibility that some sulfidopeptide leukotriene is produced by glomeruli, but it is clear that the major product of 5-lipoxygenase activity in glomeruli is LTB4. We could not detect LTB4 production by normal glomeruli, even with addition of ionophore. This is not incompatible with the recent report by Cattell and her colleagues, since they pooled glomeruli from many more rats, totaling 5 mg glomerular protein to obtain 120 pg/mg LTB4 produced by normal glomeruli without addition of ionophore (31) . We detected as much as 12 ng/mg LTB4 produced by glomeruli from rats with CBGG nephritis containing only 0.5 mg protein; this is clearly different from the synthetic rate of normal glomeruli, whether or not stimulated with ionophore.
The enhanced glomerular LTB4 synthesis in the CBGG model could be derived from endogenous glomerular cells, or circulating neutrophils or monocytes trapped in the glomeruli during glomerular isolation. Although there were no infiltrating monocytes or neutrophils in glomeruli demonstrable by light and electron microscopy in this model, it is conceivable that there were some circulating cells present in the glomeruli not demonstrated by routine morphologic examination (21, 32) . The contribution of these cells to the glomerular LTB4 should be minimal, if any. This is supported by our finding of increased glomerular LTB4 synthesis associated with CBGGinduced glomerulonephritis even when circulating leukocytes are reduced by > 95% through bone marrow irradiation. Furthermore, glomerular synthesis of LTB4 in rats with NSN was below the detection limit of our assay, despite heavy glomerular infiltration with neutrophils. Therefore, the most likely source of enhanced LTB4 synthesis in the CBGG model is endogenous glomerular cells. Glomerular epithelial and mesangial cells are capable of synthesizing prostaglandins, thromboxane, and 12-HETE (33) . They are a possible source of LTB4; however, their capacity to synthesize 5-lipoxygenase products has not been established. A bone marrow-derived macrophage, recently described as resident in the mesangium, increases in immune glomerular injury (32) , and could be a source of LTB4. These cells may metabolize arachidonic acid through the 5-lipoxygenase pathway similar to monocytes and macrophages. Endothelial cells in the glomeruli may also be a source of the LTB4 we observed, but this is very unlikely since endothelial cells are relatively poor producers of LTB4, generating i-LTB4 in the pg range/2 X 106 cells/h, even with 10 ,M ionophore (34) .
Regardless of the cellular source of LTB4, we consider deposited immune complexes to be the likely stimulus. Lianos recently reported transient increases in i-LTB4 synthesis within hours after induction of the heterologous phase of NSN, but noted that LTB4 synthesis did not persist until the onset of proteinuria (35) . Lianos and Noble also reported similar transient i-LTB4 synthesis in the heterologous phase of PHN and active Heymann nephritis, again not associated with proteinuria either temporally or in degree (36) . Although PHN is an immune complex disease pathologically similar to the CBGG model, we did not observe an increment in glomerular LTB4 synthesis in proteinuric rats with PHN or with NSN, in agreement with Lianos et al. (35, 36) . In contrast, in CBGG-induced glomerulonephritis there is more 5-lipoxygenation of arachidonic acid than in the other models and heightened LTB4 synthesis is sustained for at least a few days after onset of proteinuria. Hence, ongoing formation or deposition of immune complexes which persists in active models ofglomerulonephritis but occurs only transiently in the passive models might be a key factor in stimulating glomerular 5-lipoxygenase.
Data on the effects of LTB4 on glomerular function are scarce. Physiologic effects of LTB4 are most extensively studied in leukocytes. LTB4 is a potent chemotactic lipid, equipotent on molar basis to formyl-methionyl-leucyl-phenylalanine and complement component C5a, the two most potent chemotactic agents known (37, 38) . In vivo, LTB4 shows chemotactic activity towards polymorphonuclear leukocytes, monocytes, and eosinophils. Also, LTB4 can cause secretion of lysosomal enzymes from neutrophils (10, 39) , enhance complement receptor expression (40) and induce expansion of human suppressor cells (41) .
The lack of glomerular cellular infiltration in the CBGG model, despite the generation of the powerful chemotactic lipid LTB4, is consistent with the findings of Kreisle et al. (42) , who found that rat PMN do not exhibit chemotaxis to LTB4 at concentrations from 10-10 to 10-6 M. At these concentrations LTB4 can elicit a powerful chemotactic response in human PMNs. Thus, any proinflammatory effects of LTB4 in rat glomerular disease are likely mediated by mechanisms other than recruitment of inflammatory cells into the glomeruli.
We do not expect any effect of LTB4 on glomerular hemodynamics, since LTB4 has no demonstrable spasmogenic activity on rat mesangial cells in culture (43) , guinea pig ileum (44) , and rat and rabbit aorta (45) . This is in contrast to the well known contractile effects of the sulfidopeptide leukotrienes, LTC4 and LTD4 on glomeruli (46) and mesangial cells in culture (43, 46) , and on the renal vasculature (47, 48) .
Although LTB4 has no effect on vascular permeability itself, simultaneous injection of LTB4 with vasodilators such as PGE2 or bradykinin increases vascular permeability (1 1-14) .
The vasodilators alone did not increase vascular permeability even at relatively high doses, and the increase in permeability was dependent on the concentration of LTB4 injected. Although one group found no increase in vascular permeability in the kidney after infusion of both eicosanoids into the renal artery at doses that did induce increased permeability in skin and other sites, these investigators studied whole kidney rather than alterations in glomerular capillary permeability specifically (49) . These experiments were, moreover, quite acute, being terminated only 8 min after infusion of eicosanoids. Since increased glomerular synthesis ofPGE2 is a feature ofthe CBGG-induced model of glomerulonephritis (20) , synergism between increased PGE2 and LTB4 in promoting increased vascular permeability may well apply to glomerular permeability to macromolecules in this model. We administered BW755C, a combined lipoxygenase and cyclooxygenase inhibitor to a group of CBGG rats and decreased glomerular LTB4 synthesis by 65%, proteinuria by 63%, and GFR by 56%. Hence, the reduction of proteinuria after inhibition ofglomerular LTB4 could also be attributed to a reduced filtered protein load. Furthermore, BW755C is a cyclooxygenase inhibitor and undoubtedly reduced glomerular PGE2 production and removed the synergistic actions of PGE2 and LTB4 to enhance capillary permeability. The precise definition of the role of LTB4 in the CBGG model must await the availability of specific 5-lipoxygenase inhibitors and/or LTB4 receptor antagonists.
Reports of synergy between LTB4 and vasodilators in inducing vascular permeability ascribe the actions of the eicosanoids to an effect on neutrophils (11, 12, 50 ). Yet, in the CBGG-induced model of glomerulonephritis, we do not observe a cellular infiltrate (20) and in separate studies reported elsewhere, we have found that enhanced glomerular prostaglandin production and proteinuria develop independently of circulating leukocytes (30) . This does not exclude synergistic interaction between PGE2 and LTB4 in CBGG-induced glomerulonephritis; rather, it indicates that the functions subserved by neutrophils in the enhancement of cutaneous vascular permeability may be provided by cells other than circulating or infiltrating leukocytes in glomerulonephritis, perhaps endogenous glomerular cells. Glomerular mesangial cells in culture manifest several functions traditionally associated with granulocytes, including expression of receptors for immunoglobulin Fc region and for activated complement components, generation of reactive oxygen intermediates and inflammatory eicosanoids, elaboration of neutral proteases, and even phagocytosis and secretion of interleukin 1 (51, 52) . Thus, some mesangial effect of LTB4 in conjunction with PGE2 may ultimately cause proteinuria.
In summary, we examined glomerular synthetic capacity of LTB4 by normal rat glomeruli and by glomeruli isolated from the heterologous phase of NSN, PHN, and CBGG-induced membranous nephropathy. Glomerular synthesis of LTB4 was exclusively enhanced in the CBGG model independent of infiltrating leukocytes or platelets. This increment of LTB4 may play an important role in the pathophysiology of glomerular disease.
